Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Sell
47
BBC Quote, Financials, Valuation and Earnings
Last price:
$17.18
Seasonality move
:
4.9%
Day range:
$17.14 - $18.88
52-week range:
$13.42 - $31.65
Dividend yield:
1.4%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
150.5K
Avg. volume:
115.3K
1-year change:
-38.66%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Virtus LifeSci Biotech Clinical Trials ETF has -- downside to fair value with a price target of -- per share.
BBC vs. S&P 500
-
Over the past 5 trading days, Virtus LifeSci Biotech Clinical Trials ETF has underperformed the S&P 500 by -8.29% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Virtus LifeSci Biotech Clinical Trials ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Virtus LifeSci Biotech Clinical Trials ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Virtus LifeSci Biotech Clinical Trials ETF reported revenues of --.
Earnings Growth
-
Virtus LifeSci Biotech Clinical Trials ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Virtus LifeSci Biotech Clinical Trials ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-05-07 | 2024-05-07 | 2024-05-07 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-05-07 | 2022-05-07 | 2023-05-07 | 2024-05-07 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-05-07 | 2024-05-07 | 2024-05-07 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
BBC
Sector
Market Cap
--
--
Price % of 52-Week High
54.19%
--
Dividend Yield
1.4%
--
Shareholder Yield
--
--
1-Year Price Total Return
-38.66%
--
Beta (5-Year)
1.050
--
Dividend yield:
1.4%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$18.68
200-day SMA
Sell
Level
$24.54
Bollinger Bands (100)
Sell
Level
17.92 - 24.06
Chaikin Money Flow
Sell
Level
-522.9K
20-day SMA
Sell
Level
$17.36
Relative Strength Index (RSI14)
Sell
Level
43.63
ADX Line
Sell
Level
27.21
Williams %R
Neutral
Level
-71.5385
50-day SMA
Sell
Level
$18.42
MACD (12, 26)
Buy
Level
0.18
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Sell
Level
-252.8K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, BBC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BBC average analyst price target in the past 3 months is --.
-
Where Will Virtus LifeSci Biotech Clinical Trials ETF Stock Be In 1 Year?
According to analysts, the consensus estimate is that Virtus LifeSci Biotech Clinical Trials ETF share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Virtus LifeSci Biotech Clinical Trials ETF?
Analysts are divided on their view about Virtus LifeSci Biotech Clinical Trials ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Virtus LifeSci Biotech Clinical Trials ETF is a Sell and believe this share price will rise from its current level to --.
-
What Is Virtus LifeSci Biotech Clinical Trials ETF's Price Target?
The price target for Virtus LifeSci Biotech Clinical Trials ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BBC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Virtus LifeSci Biotech Clinical Trials ETF is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of BBC?
You can purchase shares of Virtus LifeSci Biotech Clinical Trials ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Virtus LifeSci Biotech Clinical Trials ETF shares.
-
What Is The Virtus LifeSci Biotech Clinical Trials ETF Share Price Today?
Virtus LifeSci Biotech Clinical Trials ETF was last trading at $17.18 per share. This represents the most recent stock quote for Virtus LifeSci Biotech Clinical Trials ETF. Yesterday, Virtus LifeSci Biotech Clinical Trials ETF closed at $17.15 per share.
-
How To Buy Virtus LifeSci Biotech Clinical Trials ETF Stock Online?
In order to purchase Virtus LifeSci Biotech Clinical Trials ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is up 34.66% over the past day.
Buy
63
SKX alert for May 7
Skechers USA [SKX] is down 0.07% over the past day.
